首页 > 最新文献

International journal of medicine最新文献

英文 中文
Extra-pulmonary tuberculosis frequency and the risk factors influence (case of the PHE-Batna regional unit) (2017-2022) 肺外结核病发病率及影响风险因素(PHE-巴特那地区单位案例)(2017-2022 年)
Pub Date : 2024-04-24 DOI: 10.14419/tyfk9r02
A. Benbouza, Y. Mebarki, N. Righi, R. Djebaili, O. Mansouri
Context: Tuberculosis is an infectious disease that is endemic in developing countries. The causal agent is Mycobacterium tuberculosis. Extra-pulmonary tuberculosis (EPTB) is receiving renewed attention due to an unexplained increase in its relative frequency. The aim of this study was to carry out a retrospective descriptive survey to assess the frequency of extra-pulmonary tuberculosis in an eastern Algeria population range.Methods: this study took place at the regional tuberculosis Batna’s Public hospitalian establishment unit; over a period of 64 months (2017-2022). 2405 files were studied through the collection of information recorded at laboratory level.Results: Out of 2405 samples, 102 were positive (4.24%). There was a clear predominance of females (64.70%) and males (35.29%), giving a sex ratio of 1.8. The age group most affected was 11 to 49. Pus was the most common specimen with a percentage of 44.12%, followed by urine (28.43%), CSF (14.70%). The incidence of extra pulmonary tuberculosis in patients in Batna’s Department and neighbouring Departments is 4.24%, with adult women being the most affected.Conclusion: Extrapulmonary tuberculosis is common and should not be neglected; it is no longer a pathology of the past but still remains relevant today.
背景:结核病是一种在发展中国家流行的传染病。病原体是结核分枝杆菌。由于肺外结核病(EPTB)的相对发病率出现不明原因的增长,它再次受到人们的关注。本研究旨在开展一项回顾性描述性调查,以评估阿尔及利亚东部人口范围内肺外结核病的发病频率。方法:本研究在地区结核病巴特纳公立医院机构进行,历时64个月(2017-2022年)。通过收集实验室记录的信息,对2405份档案进行了研究:在 2405 份样本中,102 份呈阳性(4.24%)。女性(64.70%)和男性(35.29%)明显占多数,性别比为 1.8。受影响最大的年龄组为 11 至 49 岁。脓液是最常见的标本,占 44.12%,其次是尿液(28.43%)和 CSF(14.70%)。巴特纳科和邻近科室的肺外结核病发病率为 4.24%,其中成年女性发病率最高:肺外结核病很常见,不应被忽视。
{"title":"Extra-pulmonary tuberculosis frequency and the risk factors influence (case of the PHE-Batna regional unit) (2017-2022)","authors":"A. Benbouza, Y. Mebarki, N. Righi, R. Djebaili, O. Mansouri","doi":"10.14419/tyfk9r02","DOIUrl":"https://doi.org/10.14419/tyfk9r02","url":null,"abstract":"Context: Tuberculosis is an infectious disease that is endemic in developing countries. The causal agent is Mycobacterium tuberculosis. Extra-pulmonary tuberculosis (EPTB) is receiving renewed attention due to an unexplained increase in its relative frequency. The aim of this study was to carry out a retrospective descriptive survey to assess the frequency of extra-pulmonary tuberculosis in an eastern Algeria population range.\u0000Methods: this study took place at the regional tuberculosis Batna’s Public hospitalian establishment unit; over a period of 64 months (2017-2022). 2405 files were studied through the collection of information recorded at laboratory level.\u0000Results: Out of 2405 samples, 102 were positive (4.24%). There was a clear predominance of females (64.70%) and males (35.29%), giving a sex ratio of 1.8. The age group most affected was 11 to 49. Pus was the most common specimen with a percentage of 44.12%, followed by urine (28.43%), CSF (14.70%). The incidence of extra pulmonary tuberculosis in patients in Batna’s Department and neighbouring Departments is 4.24%, with adult women being the most affected.\u0000Conclusion: Extrapulmonary tuberculosis is common and should not be neglected; it is no longer a pathology of the past but still remains relevant today.","PeriodicalId":91290,"journal":{"name":"International journal of medicine","volume":"105 12","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140659589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors limiting exercise capacity in COPD patients 限制慢性阻塞性肺病患者运动能力的因素
Pub Date : 2024-04-05 DOI: 10.14419/mrga5j48
R. Djebaili, N. Righi, A. Benbouza, B. Chiboub
Introduction: Impaired exercise capacity in COPD patients leads to deterioration in their physical activity and quality of life. The aim of our study was to assess the exercise capacity of COPD patients using the 6-minute walk test (6MWT) and to determine the factors limiting their exercise capacity.Methods: Stable COPD patients were included in this study to assess their exercise capacity using the 6-minute walk test (6MWT) and to investigate the relationship between exercise capacity, functional status (FEV1), quadriceps muscle dysfunction (strength and endurance), and fat free mass index (FFMI).Results: 175 COPD patients (166 males and 9 females) aged between 40 and 86 years with a mean age of 67.95 years. The functional stages distribution according to GOLD was GOLDI: 19.43%, GOLDII: 30.29%, GOLDIII: 33.71%, GOLD IV: 16.57%. 25% of patients received long-term oxygen therapy (LTOT). The mean distance covered by COPD patients was 432.26 ± 129.731 meters, corresponding to 64.71 ± 19.04%. 56 (32%) COPD patients had exercise intolerance as assessed by the distance walked over 6 minutes (6MWD). A significant correlation was found between the 6MWD, quadriceps endurance (P<0.000) and FEV1 (p<0.002), whereas no correlation was found with MVC (P<0.039) and (FFMI) (P<0.062).Conclusion: Muscle dysfunction and the severity of bronchial obstruction are the factors most associated with impaired exercise capacity in COPD patients.
导言:慢性阻塞性肺病患者的运动能力受损会导致其身体活动和生活质量下降。我们的研究旨在使用 6 分钟步行测试(6MWT)评估慢性阻塞性肺病患者的运动能力,并确定限制其运动能力的因素:本研究纳入了病情稳定的慢性阻塞性肺病患者,使用 6 分钟步行测试(6MWT)评估他们的运动能力,并调查运动能力、功能状态(FEV1)、股四头肌功能障碍(力量和耐力)和无脂肪体重指数(FFMI)之间的关系:175名慢性阻塞性肺病患者(男性166人,女性9人)的年龄在40至86岁之间,平均年龄为67.95岁。根据 GOLD 的功能分期,GOLDI:19.43%,GOLDII:30.29%,GOLDIII:33.71%,GOLD IV:16.57%。25%的患者接受了长期氧疗(LTOT)。慢性阻塞性肺病患者的平均行走距离为 432.26 ± 129.731 米,占 64.71 ± 19.04%。根据 6 分钟步行距离(6MWD)评估,56 名(32%)慢性阻塞性肺病患者存在运动不耐受问题。6MWD、股四头肌耐力(P<0.000)和 FEV1(P<0.002)之间存在明显的相关性,而 MVC(P<0.039)和(FFMI)(P<0.062)之间没有相关性:结论:肌肉功能障碍和支气管阻塞的严重程度是慢性阻塞性肺病患者运动能力受损的最大相关因素。
{"title":"Factors limiting exercise capacity in COPD patients","authors":"R. Djebaili, N. Righi, A. Benbouza, B. Chiboub","doi":"10.14419/mrga5j48","DOIUrl":"https://doi.org/10.14419/mrga5j48","url":null,"abstract":"Introduction: Impaired exercise capacity in COPD patients leads to deterioration in their physical activity and quality of life. The aim of our study was to assess the exercise capacity of COPD patients using the 6-minute walk test (6MWT) and to determine the factors limiting their exercise capacity.\u0000Methods: Stable COPD patients were included in this study to assess their exercise capacity using the 6-minute walk test (6MWT) and to investigate the relationship between exercise capacity, functional status (FEV1), quadriceps muscle dysfunction (strength and endurance), and fat free mass index (FFMI).\u0000Results: 175 COPD patients (166 males and 9 females) aged between 40 and 86 years with a mean age of 67.95 years. The functional stages distribution according to GOLD was GOLDI: 19.43%, GOLDII: 30.29%, GOLDIII: 33.71%, GOLD IV: 16.57%. 25% of patients received long-term oxygen therapy (LTOT). The mean distance covered by COPD patients was 432.26 ± 129.731 meters, corresponding to 64.71 ± 19.04%. 56 (32%) COPD patients had exercise intolerance as assessed by the distance walked over 6 minutes (6MWD). A significant correlation was found between the 6MWD, quadriceps endurance (P<0.000) and FEV1 (p<0.002), whereas no correlation was found with MVC (P<0.039) and (FFMI) (P<0.062).\u0000Conclusion: Muscle dysfunction and the severity of bronchial obstruction are the factors most associated with impaired exercise capacity in COPD patients.","PeriodicalId":91290,"journal":{"name":"International journal of medicine","volume":"24 7","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140736595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unravelling the Enigma: A Study on Exploring the Idiopathic Surge in Serum Alkaline Phosphatase Level 揭开谜底探究血清碱性磷酸酶水平突增的特发性研究
Pub Date : 2024-03-16 DOI: 10.14419/3fvczb37
Vishal Kr
A 73 year old Indian female with type O blood group came for routine checkup when it was discovered she had elevated levels of serum alkaline phosphatase (600 mg/dL). Other liver function tests were within normal limits. Abdominal imaging revealed grade I fatty liver but an extensive serological search for significant hepatobiliary disease was negative. She is currently under medication for diabetes and hypertension, association with raised enzyme level couldn't be interpreted due to paucity of testing.
一位 73 岁的印度女性,O 型血,来做常规体检时发现血清碱性磷酸酶水平升高(600 毫克/分升)。其他肝功能检查均在正常范围内。腹部影像学检查显示她患有 I 级脂肪肝,但对她进行的重大肝胆疾病血清学检查结果为阴性。她目前正在服用治疗糖尿病和高血压的药物,由于检测项目较少,无法解释酶水平升高的关联。
{"title":"Unravelling the Enigma: A Study on Exploring the Idiopathic Surge in Serum Alkaline Phosphatase Level","authors":"Vishal Kr","doi":"10.14419/3fvczb37","DOIUrl":"https://doi.org/10.14419/3fvczb37","url":null,"abstract":"A 73 year old Indian female with type O blood group came for routine checkup when it was discovered she had elevated levels of serum alkaline phosphatase (600 mg/dL). Other liver function tests were within normal limits. Abdominal imaging revealed grade I fatty liver but an extensive serological search for significant hepatobiliary disease was negative. She is currently under medication for diabetes and hypertension, association with raised enzyme level couldn't be interpreted due to paucity of testing.","PeriodicalId":91290,"journal":{"name":"International journal of medicine","volume":"105 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140236701","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lung cancer, predictive factor and ERCC1 肺癌、预测因子和 ERCC1
Pub Date : 2024-03-06 DOI: 10.14419/378xkf63
Souad Souilah
Introduction: Excision repair cross-complementing group 1 (ERCC1) counteracts the cytotoxic effect of cisplatin through its role in DNA repair, and its expression level is a crucial factor for sensitivity to this drug. The objective of this study was to assess the impact of ERCC1 on tumor response and survival in patients with advanced non-small cell lung cancer (NSCLC) treated with a platinum-based regimen.Methods: Analysis of survival and tumor response based on the expression level of ERCC1 (detected by immunohistochemistry) in a cohort of NSCLC patients followed in a standard care setting.Results: Among the 77 cases of NSCLC included, ERCC1 expression was low in 64.9% of cases and high in 35.1% of cases. In the 52 patients treated with cisplatin, survival and tumor response were better in the low-expression group compared to the high-expression group: 14.35 months versus 9.49 months, p=0.022; Objective Response: 42.4% versus 0%, p=0.001. No significant difference was found based on protein expression level in patients treated with carboplatin.Conclusion: ERCC1 overexpression in patients treated with cisplatin predicts a poor tumor response and shorter survival.
导言切除修复交叉互补基团1(ERCC1)通过其在DNA修复中的作用抵消顺铂的细胞毒性作用,其表达水平是顺铂药物敏感性的关键因素。本研究旨在评估ERCC1对接受铂类药物治疗的晚期非小细胞肺癌(NSCLC)患者的肿瘤反应和生存期的影响:方法:根据ERCC1的表达水平(通过免疫组化方法检测)分析标准治疗中NSCLC患者的生存率和肿瘤反应:在77例NSCLC患者中,64.9%的患者ERCC1表达水平较低,35.1%的患者ERCC1表达水平较高。在接受顺铂治疗的52例患者中,低表达组的生存期和肿瘤反应优于高表达组:14.35个月对9.49个月,P=0.022;客观反应:42.4%对0%:42.4%对0%,P=0.001。卡铂治疗患者的蛋白表达水平无明显差异:结论:顺铂治疗患者的ERCC1过表达预示着肿瘤反应较差和生存期较短。
{"title":"Lung cancer, predictive factor and ERCC1","authors":"Souad Souilah","doi":"10.14419/378xkf63","DOIUrl":"https://doi.org/10.14419/378xkf63","url":null,"abstract":"Introduction: Excision repair cross-complementing group 1 (ERCC1) counteracts the cytotoxic effect of cisplatin through its role in DNA repair, and its expression level is a crucial factor for sensitivity to this drug. The objective of this study was to assess the impact of ERCC1 on tumor response and survival in patients with advanced non-small cell lung cancer (NSCLC) treated with a platinum-based regimen.\u0000Methods: Analysis of survival and tumor response based on the expression level of ERCC1 (detected by immunohistochemistry) in a cohort of NSCLC patients followed in a standard care setting.\u0000Results: Among the 77 cases of NSCLC included, ERCC1 expression was low in 64.9% of cases and high in 35.1% of cases. In the 52 patients treated with cisplatin, survival and tumor response were better in the low-expression group compared to the high-expression group: 14.35 months versus 9.49 months, p=0.022; Objective Response: 42.4% versus 0%, p=0.001. No significant difference was found based on protein expression level in patients treated with carboplatin.\u0000Conclusion: ERCC1 overexpression in patients treated with cisplatin predicts a poor tumor response and shorter survival.","PeriodicalId":91290,"journal":{"name":"International journal of medicine","volume":"13 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140263096","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognosis and survival of lung cancer in the elderly 老年人肺癌的预后和存活率
Pub Date : 2024-03-06 DOI: 10.14419/m01nz878
Souad Souilah, Nassima Djami
Introduction: In our department, from 2012 to 2020, 33.3% of patients treated for lung cancer were over 70 years old. Our study aimed to estimate overall survival and investigate the significance of prognostic factors in a population of 308 patients aged over 70 with lung cancer, collected from January 2012 to June 2020.Methods: The initial assessment included at least a bronchoscopic examination and thoracic computed tomography. Survival rates were calculated using the Kaplan-Meier method and presented with 95% confidence intervals. The Log-Rank test was utilized for the comparison of survival curves.Results: The 308 cases (9.6% females, 90.4% males) included 92.2% NSCLC (49.6% squamous cell, 45.4% adenocarcinomas) and 7.8% SCLC. The median age at diagnosis was 74 years, 14.6% were non-smokers, and 55.8% were former smokers. 67.9% of patients had at least one comorbidity, 1.6% had a PS equal to 0, and 28.2% had a PS ≥ 2. TNM staging found 9.2% of cases at stages I and II; 31.2% at stage III, and 59.7% at stage IV. The median overall survival was 8.312 months [6.947-9.678], and the 1-year survival rate was 35.1%. Better survival was correlated with female gender, absence of smoking, PS ≤ 1, and TNM staging.Conclusion: All standard therapeutic options for bronchial cancer can be considered in the elderly, but physiological aging and the prevalence of comorbidities alter the risk-benefit ratio of treatments. This emphasizes the need for the implementation of a comprehensive management strategy for this segment of society.
导言从2012年到2020年,在我院接受治疗的肺癌患者中,有33.3%的患者年龄超过70岁。我们的研究旨在估算2012年1月至2020年6月期间308名70岁以上肺癌患者的总生存率,并调查预后因素的重要性:初步评估至少包括支气管镜检查和胸部计算机断层扫描。采用卡普兰-梅耶法计算生存率,并给出95%的置信区间。采用 Log-Rank 检验比较生存曲线:308例病例中(女性占9.6%,男性占90.4%),92.2%为NSCLC(49.6%为鳞癌,45.4%为腺癌),7.8%为SCLC。确诊时的中位年龄为 74 岁,14.6% 不吸烟,55.8% 曾经吸烟。67.9%的患者至少有一种合并症,1.6%的患者PS等于0,28.2%的患者PS≥2。TNM分期发现,9.2%的病例处于I期和II期,31.2%处于III期,59.7%处于IV期。中位总生存期为 8.312 个月 [6.947-9.678],1 年生存率为 35.1%。较好的生存率与女性性别、不吸烟、PS≤1和TNM分期有关:结论:老年人可以考虑支气管癌的所有标准治疗方案,但生理衰老和合并症的流行会改变治疗的风险效益比。这强调了对这部分人群实施综合管理策略的必要性。
{"title":"Prognosis and survival of lung cancer in the elderly","authors":"Souad Souilah, Nassima Djami","doi":"10.14419/m01nz878","DOIUrl":"https://doi.org/10.14419/m01nz878","url":null,"abstract":"Introduction: In our department, from 2012 to 2020, 33.3% of patients treated for lung cancer were over 70 years old. Our study aimed to estimate overall survival and investigate the significance of prognostic factors in a population of 308 patients aged over 70 with lung cancer, collected from January 2012 to June 2020.\u0000Methods: The initial assessment included at least a bronchoscopic examination and thoracic computed tomography. Survival rates were calculated using the Kaplan-Meier method and presented with 95% confidence intervals. The Log-Rank test was utilized for the comparison of survival curves.\u0000Results: The 308 cases (9.6% females, 90.4% males) included 92.2% NSCLC (49.6% squamous cell, 45.4% adenocarcinomas) and 7.8% SCLC. The median age at diagnosis was 74 years, 14.6% were non-smokers, and 55.8% were former smokers. 67.9% of patients had at least one comorbidity, 1.6% had a PS equal to 0, and 28.2% had a PS ≥ 2. TNM staging found 9.2% of cases at stages I and II; 31.2% at stage III, and 59.7% at stage IV. The median overall survival was 8.312 months [6.947-9.678], and the 1-year survival rate was 35.1%. Better survival was correlated with female gender, absence of smoking, PS ≤ 1, and TNM staging.\u0000Conclusion: All standard therapeutic options for bronchial cancer can be considered in the elderly, but physiological aging and the prevalence of comorbidities alter the risk-benefit ratio of treatments. This emphasizes the need for the implementation of a comprehensive management strategy for this segment of society.","PeriodicalId":91290,"journal":{"name":"International journal of medicine","volume":"5 12","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140261046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incidence of healthcare-associated infections in intensive care of the emergency department of Oran in Algeria 阿尔及利亚奥兰市急诊科重症监护室的医源性感染发生率
Pub Date : 2024-02-12 DOI: 10.14419/623sj981
Soumia Benbernou, Nabil Ghoumari, Fouzia Kambouche, Rabah Kouadria
Introduction. Healthcare-associated infections (HAIs) are a serious problem of modern medicine. Patients hospitalized in intensive care units (ICUs) develop HAI significantly more often than patients in other hospital units.Materials and Methods.We carried out a retrospective study spread over 2 years from January 2019 to December 2021. Data were collected on a form established with the microbiology department of the the University Hospital center of Oran, sites of nosocomial infection, germs involved, antibiotic resistance.Results: 886 samples were collected during the study period, of which 660 were positive. 270 patients were admitted to hospital during this period. The average age of our patients was 39.4 years. The most frequently isolated bacteria were Klebsiella pneumoniae ,Acinetobacter baumannii ,Staphylococcus aureus ,and Escherichia coli .Conclusion Infection control based on incidence rate for each type of infection is necessary in ICU to assess the epidemiological situation. 
导言。医疗相关感染(HAI)是现代医学的一个严重问题。在重症监护病房(ICU)住院的患者发生 HAI 的频率明显高于其他医院病房的患者。我们通过与奥兰大学医院中心微生物部共同制定的表格收集数据,包括医院内感染的发生部位、涉及的病菌、抗生素耐药性等:研究期间共采集了 886 份样本,其中 660 份呈阳性。在此期间有 270 名患者入院治疗。患者的平均年龄为 39.4 岁。最常分离到的细菌是肺炎克雷伯菌、鲍曼不动杆菌、金黄色葡萄球菌和大肠埃希菌。
{"title":"Incidence of healthcare-associated infections in intensive care of the emergency department of Oran in Algeria","authors":"Soumia Benbernou, Nabil Ghoumari, Fouzia Kambouche, Rabah Kouadria","doi":"10.14419/623sj981","DOIUrl":"https://doi.org/10.14419/623sj981","url":null,"abstract":"Introduction. Healthcare-associated infections (HAIs) are a serious problem of modern medicine. Patients hospitalized in intensive care units (ICUs) develop HAI significantly more often than patients in other hospital units.\u0000Materials and Methods.\u0000We carried out a retrospective study spread over 2 years from January 2019 to December 2021. Data were collected on a form established with the microbiology department of the the University Hospital center of Oran, sites of nosocomial infection, germs involved, antibiotic resistance.\u0000Results: 886 samples were collected during the study period, of which 660 were positive. 270 patients were admitted to hospital during this period. The average age of our patients was 39.4 years. The most frequently isolated bacteria were Klebsiella pneumoniae ,Acinetobacter baumannii ,Staphylococcus aureus ,and Escherichia coli .\u0000Conclusion Infection control based on incidence rate for each type of infection is necessary in ICU to assess the epidemiological situation.\u0000 ","PeriodicalId":91290,"journal":{"name":"International journal of medicine","volume":"364 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140458649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Profile of adult patients hospitalized for asthma exacerbation 因哮喘恶化住院的成年患者概况
Pub Date : 2024-02-12 DOI: 10.14419/54x2qn94
Faouzia Kambouche, Rabia Medjane
A variable proportion of patients presenting to the emergency department (ED) with acute asthma require admission to hospital. Previous studies have identified select factors associated with admission following ED presentation .However, patients hospitalized for AEs are highly heterogeneous and remain largely unexplored.This review discusses current aspects on the pathogenesis and pathophysiology of acute severe asthma exacerbations and provides the current perspectives on the management of acute severe asthma attacks in the emergency department and the intensive care unit.
在急诊科(ED)就诊的急性哮喘患者中,需要入院治疗的患者比例不等。本综述讨论了当前严重哮喘急性加重的发病机制和病理生理学方面的问题,并对急诊科和重症监护室处理严重哮喘急性发作的方法进行了展望。
{"title":"Profile of adult patients hospitalized for asthma exacerbation","authors":"Faouzia Kambouche, Rabia Medjane","doi":"10.14419/54x2qn94","DOIUrl":"https://doi.org/10.14419/54x2qn94","url":null,"abstract":"A variable proportion of patients presenting to the emergency department (ED) with acute asthma require admission to hospital. Previous studies have identified select factors associated with admission following ED presentation .However, patients hospitalized for AEs are highly heterogeneous and remain largely unexplored.This review discusses current aspects on the pathogenesis and pathophysiology of acute severe asthma exacerbations and provides the current perspectives on the management of acute severe asthma attacks in the emergency department and the intensive care unit.","PeriodicalId":91290,"journal":{"name":"International journal of medicine","volume":"317 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140458428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exercise training: which impact on COPD patients? 运动训练:对慢性阻塞性肺病患者有何影响?
Pub Date : 2024-01-15 DOI: 10.14419/xya73q42
R. Djebaili, B. Chiboub
Introduction: Exercise training reactivates the aerobic pathway through physical exercise, thereby improving dyspnea and breaking deconditioning spiral in chronic obstructive pulmonary disease (COPD) patients.Method: 60 COPD patients were selected to benefit from a four-week outpatient exercise training and muscle strengthening program, at a rate of 3 sessions per week, after excluding the following cases: patients who have contraindications to exercise training; severe patients or those receiving long-term oxygen therapy. The program combined exercise training on a bicycle ergometer for 45 min, muscle strengthening of the lower limbs and nutritional monitoring. Nutritional management included a diet based on nutritional status and the prescription of oral food supplements for malnourished COPD patients. Parameters assessed before and after training were bioimpedance analysis (BIA),6MWT, quadriceps isometric voluntary contraction (MVC) and dynamic endurance, and the quality-of-life questionnaire (Q11).Result: Forty COPD patients (36 men and 4 women) aged 67.22 (± 10) years were able to complete the program. Amid them, 36 were non-smokers. Ten patients (GOLD I), 14 patients (GOLD II), 16 patients (GOLD III), no patients (GOLD IV). Dyspnea was stage 2 (± 1) m MRC. After training, quadriceps muscle function ((MVC) and endurance) improved significantly (p < 0.0001). The improvement in distance covered during 6MWT was also significant (p < 0.0001). A significant improvement in quality of life after training was noted on the total score of the Q11 questionnaire. No significant improvement in body composition after training in COPD patients.Conclusion: this study has confirmed the beneficial effects of training mainly on muscle function, effort capacity and quality of life in COPD patients.
导言运动训练可通过体育锻炼重新激活有氧途径,从而改善慢性阻塞性肺病(COPD)患者的呼吸困难,并打破减重螺旋:筛选出 60 名慢性阻塞性肺病患者,对其进行为期四周的门诊运动训练和肌肉强化训练,每周 3 次,并排除以下情况:有运动训练禁忌症的患者;重症患者或长期接受氧疗的患者。该计划包括在自行车测力计上进行 45 分钟的运动训练、下肢肌肉强化训练和营养监测。营养管理包括根据营养状况安排饮食,以及为营养不良的慢性阻塞性肺病患者开具口服食物补充剂处方。训练前后的评估参数包括生物阻抗分析(BIA)、6MWT、股四头肌等长自主收缩(MVC)和动态耐力以及生活质量问卷(Q11):结果:40 名慢性阻塞性肺病患者(36 名男性和 4 名女性)完成了该项目,年龄为 67.22(± 10)岁。其中 36 人为非吸烟者。10名患者(GOLD I),14名患者(GOLD II),16名患者(GOLD III),无患者(GOLD IV)。呼吸困难程度为 MRC 2 期(± 1)。训练后,股四头肌功能((MVC)和耐力)显著改善(P < 0.0001)。6MWT运动距离的改善也很明显(P < 0.0001)。从 Q11 问卷的总分来看,训练后生活质量明显改善。结论:本研究证实了训练主要对慢性阻塞性肺病患者的肌肉功能、努力能力和生活质量有益。
{"title":"Exercise training: which impact on COPD patients?","authors":"R. Djebaili, B. Chiboub","doi":"10.14419/xya73q42","DOIUrl":"https://doi.org/10.14419/xya73q42","url":null,"abstract":"Introduction: Exercise training reactivates the aerobic pathway through physical exercise, thereby improving dyspnea and breaking deconditioning spiral in chronic obstructive pulmonary disease (COPD) patients.\u0000Method: 60 COPD patients were selected to benefit from a four-week outpatient exercise training and muscle strengthening program, at a rate of 3 sessions per week, after excluding the following cases: patients who have contraindications to exercise training; severe patients or those receiving long-term oxygen therapy. The program combined exercise training on a bicycle ergometer for 45 min, muscle strengthening of the lower limbs and nutritional monitoring. Nutritional management included a diet based on nutritional status and the prescription of oral food supplements for malnourished COPD patients. Parameters assessed before and after training were bioimpedance analysis (BIA),6MWT, quadriceps isometric voluntary contraction (MVC) and dynamic endurance, and the quality-of-life questionnaire (Q11).\u0000Result: Forty COPD patients (36 men and 4 women) aged 67.22 (± 10) years were able to complete the program. Amid them, 36 were non-smokers. Ten patients (GOLD I), 14 patients (GOLD II), 16 patients (GOLD III), no patients (GOLD IV). Dyspnea was stage 2 (± 1) m MRC. After training, quadriceps muscle function ((MVC) and endurance) improved significantly (p < 0.0001). The improvement in distance covered during 6MWT was also significant (p < 0.0001). A significant improvement in quality of life after training was noted on the total score of the Q11 questionnaire. No significant improvement in body composition after training in COPD patients.\u0000Conclusion: this study has confirmed the beneficial effects of training mainly on muscle function, effort capacity and quality of life in COPD patients.","PeriodicalId":91290,"journal":{"name":"International journal of medicine","volume":"5 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140508612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pulmonary tuberculosis and venous thromboembolism 肺结核与静脉血栓栓塞症
Pub Date : 2024-01-06 DOI: 10.14419/3aymyf47
Faouzia Kambouche, Labdouni Mohamed El Habib
Acute infections are among the risk factors for venous thromboembolism (VTE). The role of chronic infections such as active tuberculosis is poorly defined, although several case reports and case series have suggested a link association between tuberculosis and VTE. The unexpected resurgence of tuberculosis (TB) in developed countries provided the rationale for evaluating VTE as a possible complication of TB; never theless, the topic has received little attention in the literature.Patient and Method: This is a prospective multicenter study done between January 2016 and January 2018. It is about 17 cases of confirmed pulmonary tuberculosis associated with deep vein thrombosis.Results: It is about fifteen men and two women, their average age is 44,88 years. The thromboembolic complication revealed tuberculosis among 2patients, appearing during the hospitalization of 15 patients among which 11of them receiving antituberculosis drug. We have listed 3 cases of immediate pulmonary embolism and 14cases of deep vein thrombosis complicated with pulmonary embolism in 7 cases. These patients received anti-tuberculosis treatment according to the 2RHZE / 4RH protocol and a curative anticoagulant treatment based on low molecular weight heparin. A relay by vitamin K antagonists was instituted after a satisfactory INR control. The average time to effective anticoagulation was 15.12 days with extremes between 08 and 50 days.There was favorable evolution among 14 patients, 1of them was lost to follow-up. Sight and the evolution has been fatal in two case.Conclusion: Thromboembolic (DVT) disease must be sought systematically in the TB patients because of the risk of this complication particularly in extensive and severe forms. Prophylactic anticoagulation therapy finds its indications in these forms.
急性感染是静脉血栓栓塞症(VTE)的危险因素之一。慢性感染(如活动性肺结核)的作用尚不明确,但一些病例报告和系列病例表明肺结核与 VTE 之间存在联系。肺结核(TB)在发达国家的意外复发为评估 VTE 可能是肺结核并发症提供了依据;尽管如此,该主题在文献中却很少受到关注:这是一项前瞻性多中心研究,研究时间为 2016 年 1 月至 2018 年 1 月。患者和方法:这是一项前瞻性多中心研究,研究时间为 2016 年 1 月至 2018 年 1 月,研究对象为 17 例确诊肺结核伴有深静脉血栓形成的患者:其中男性 15 例,女性 2 例,平均年龄 44.88 岁。血栓栓塞并发症显示2名患者患有肺结核,在15名患者住院期间出现,其中11名患者正在接受抗结核药物治疗。我们列出了 3 例直接肺栓塞病例和 14 例深静脉血栓形成并发肺栓塞病例(7 例)。这些患者均按照 2RHZE / 4RH 方案接受了抗结核治疗,并接受了以低分子量肝素为基础的治疗性抗凝剂治疗。在 INR 控制令人满意后,开始使用维生素 K 拮抗剂进行中继治疗。有效抗凝时间平均为 15.12 天,最长为 08 至 50 天。结论:血栓栓塞(深静脉血栓)是一种常见的并发症:结论:肺结核患者必须系统地检查血栓栓塞(深静脉血栓)疾病,因为这种并发症的风险很高,尤其是在广泛和严重的情况下。预防性抗凝疗法适用于这些病例。
{"title":"Pulmonary tuberculosis and venous thromboembolism","authors":"Faouzia Kambouche, Labdouni Mohamed El Habib","doi":"10.14419/3aymyf47","DOIUrl":"https://doi.org/10.14419/3aymyf47","url":null,"abstract":"Acute infections are among the risk factors for venous thromboembolism (VTE). The role of chronic infections such as active tuberculosis is poorly defined, although several case reports and case series have suggested a link association between tuberculosis and VTE. The unexpected resurgence of tuberculosis (TB) in developed countries provided the rationale for evaluating VTE as a possible complication of TB; never theless, the topic has received little attention in the literature.\u0000Patient and Method: This is a prospective multicenter study done between January 2016 and January 2018. It is about 17 cases of confirmed pulmonary tuberculosis associated with deep vein thrombosis.\u0000Results: It is about fifteen men and two women, their average age is 44,88 years. The thromboembolic complication revealed tuberculosis among 2patients, appearing during the hospitalization of 15 patients among which 11of them receiving antituberculosis drug. We have listed 3 cases of immediate pulmonary embolism and 14cases of deep vein thrombosis complicated with pulmonary embolism in 7 cases. These patients received anti-tuberculosis treatment according to the 2RHZE / 4RH protocol and a curative anticoagulant treatment based on low molecular weight heparin. A relay by vitamin K antagonists was instituted after a satisfactory INR control. The average time to effective anticoagulation was 15.12 days with extremes between 08 and 50 days.\u0000There was favorable evolution among 14 patients, 1of them was lost to follow-up. Sight and the evolution has been fatal in two case.\u0000Conclusion: Thromboembolic (DVT) disease must be sought systematically in the TB patients because of the risk of this complication particularly in extensive and severe forms. Prophylactic anticoagulation therapy finds its indications in these forms.","PeriodicalId":91290,"journal":{"name":"International journal of medicine","volume":"8 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140513003","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Non-alcoholic fatty liver disease in asymptomatic young adults: association with HOMA, metabolic syndrome, and atherogenic risk 无症状年轻人的非酒精性脂肪性肝病:与HOMA、代谢综合征和动脉粥样硬化风险的关系
Pub Date : 2022-12-15 DOI: 10.14419/ijm.v10i1.32185
Jorge Teodoro Chávez-Pagola, A. Hernández-Zavala, O. Valenzuela-Limón, M. Sánchez-Gutiérrez, J. Izquierdo-Vega
Objective: Non-alcoholic fatty liver disease (NAFLD) represents the most common liver disease worldwide. The Latin American population has the highest obesity rates in the world. The aim was to research the factors associated with NAFLD in young adults. Methods: A cross-sectional study was performed on 171 participants with an average age of 21 years who underwent a physical and laboratory examination, anthropometric evaluation, and abdominal ultrasound. Results: Subjects with NAFLD were significantly overweight, with dyslipidemia, and with atherogenic risk. They had the presence of metabolic syndrome compared to those without NAFLD. Bivariate logistic regression showed that body mass index, atherogenic risk, Homeostatic Model Assessment (HOMA) value, and metabolic syndrome were associated with NAFLD development. Conclusions: The variables of HOMA, metabolic syndrome, and atherogenic risk were most associated as risk predictors of this pathology in young adults.
目的:非酒精性脂肪性肝病(NAFLD)是世界范围内最常见的肝脏疾病。拉丁美洲人口的肥胖率是世界上最高的。目的是研究与年轻人NAFLD相关的因素。方法:对171名平均年龄为21岁的参与者进行了横断面研究,他们接受了身体和实验室检查、人体测量评估和腹部超声检查。结果:NAFLD患者有明显超重、血脂异常和动脉粥样硬化风险。与没有NAFLD的人相比,他们有代谢综合征的存在。双变量logistic回归显示,体重指数、动脉粥样硬化风险、稳态模型评估(HOMA)值和代谢综合征与NAFLD的发生有关。结论:在年轻人中,HOMA、代谢综合征和动脉粥样硬化风险是最相关的风险预测因素。
{"title":"Non-alcoholic fatty liver disease in asymptomatic young adults: association with HOMA, metabolic syndrome, and atherogenic risk","authors":"Jorge Teodoro Chávez-Pagola, A. Hernández-Zavala, O. Valenzuela-Limón, M. Sánchez-Gutiérrez, J. Izquierdo-Vega","doi":"10.14419/ijm.v10i1.32185","DOIUrl":"https://doi.org/10.14419/ijm.v10i1.32185","url":null,"abstract":"Objective: Non-alcoholic fatty liver disease (NAFLD) represents the most common liver disease worldwide. The Latin American population has the highest obesity rates in the world. The aim was to research the factors associated with NAFLD in young adults. Methods: A cross-sectional study was performed on 171 participants with an average age of 21 years who underwent a physical and laboratory examination, anthropometric evaluation, and abdominal ultrasound. Results: Subjects with NAFLD were significantly overweight, with dyslipidemia, and with atherogenic risk. They had the presence of metabolic syndrome compared to those without NAFLD. Bivariate logistic regression showed that body mass index, atherogenic risk, Homeostatic Model Assessment (HOMA) value, and metabolic syndrome were associated with NAFLD development. Conclusions: The variables of HOMA, metabolic syndrome, and atherogenic risk were most associated as risk predictors of this pathology in young adults.","PeriodicalId":91290,"journal":{"name":"International journal of medicine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48948116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International journal of medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1